Maky Zanganeh, Co-CEO & President at Summit Therapeutics Inc. (SMMT), bought 11,618,264 shares at $0.97 ($11.3M) on 2022-08-16, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.97 | 184,430 | $179K | 1.6% |
| 2 | $0.97 | 184,430 | $179K | 1.6% |
| 3 | $0.97 | 1,030,925 | $1000K | 8.9% |
| 4 | $0.97 | 1,030,925 | $1000K | 8.9% |
| 5 | $0.97 | 4,593,777 | $4.5M | 39.5% |
| 6 | $0.97 | 4,593,777 |
| $4.5M |
| 39.5% |
| Total | $0.97 avg | 11,618,264 | $11.3M | 100% |
| Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |
| PLSE | BUY | 2017-12-15 | $26K | — | Filing → |